Current clinical trials for the treatment of adult Hodgkin's disease: Common strategies and perspectives

Annals of Oncology

Volumn 9, Issue SUPPL. 5, 1998, Pages

  Wolf, J ^a   Tesch, H ^a   Parsa Parsi, R ^a   Engert, A ^a   Diehl, V ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Clinical trials; Dose intensification; Extended field irradiation; Hodgkin's disease

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

BLOOD TOXICITY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CHEMOSENSITIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; HEART MUSCLE INJURY; HODGKIN DISEASE; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RADIATION INJURY; SECOND CANCER; TREATMENT PLANNING;

EID: 0032465053     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/9.suppl_5.S79     Document Type: Conference Paper

References (5)

1. Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's Disease. Ann Oncol 1992; 3 (Suppl 4): 117.
2. Van Leeuven FE, Klomnan WJ, Hagenbeek A et al. Second cancer following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 1994; 12:312.
3. Canellos GP, Propert K, Cooper R et al. MOPP vs. ABVD vs. MOPP alternating with ABVD in advanced Hodgkin's disease: A prospective randomized CALGB trial. Proc Am Soc Clin Ocol 1988 (Abstr 230).
4. Connors JM, Klimo P, Adams G et al. Treatment of advanced Hodgkin's disease with chemotherapy - comparison of MOPP/ ABV hybrid regimen with alternating courses of MOPP and ABVD: A report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1997; 15: 1638.
5. Duggan D, Petroni G, Johnson J et al. MOPP/ABV versus ABVD for advanced Hodgkin's disease - a preliminary report of CALBG 8952 (with SWOG, ECOG; NCIC). Proc Am Soc Clin Oncol 1997 (Abstr 43).